의약품 관련 법령
Disposition 1686/2018: Amends Disposition 8259/2017 wihch Determines the Reference Product for Performing Chemical and Physical Tests for Levothyroxine
| 작성자 | 관리자 | ||
|---|---|---|---|
| 작성일 | 2018-11-13 | 조회수 | 810 |
| 국가정보 | 남 아메리카>아르헨티나 | ||
| 출처 | |||
| 원문 | www.boletinoficial.gov.ar | ||
| 첨부파일 | |||
Disposition 1686_2018_ Amends Disposition 8259_2017 wihch Determines the Reference Product for Performing Chemical and Physical Tests for Levothyroxine.pdf(140.7KB)Amends the second part of the Consideration of Disposition 8259/2017 which establishes the T4 Montpellier/Levothyroxine, Grooved Tablets as a reference product for performing chemical and physical tests for Levothyroxine.
- 이전글 PEI Information Note: Notice of Authorization for Medicinal Products - Ordering the use of the Online Database of the Paul Ehrlich Institute to Exclude Donations for the Production of Blood Preparations by Travelers Returning from Endemic Areas
- 다음글 BfArM Form: Notification by the Pharmacovigilance Commissioner
